BRIAN NAGLE

Monitor and engage on legislative and administrative action on appropriations and budget. Monitor and engage on the implementation of the Infrastructure Investment and Jobs Act (P.L. 117-58), and the Inflation Reduction Act of 2022 (P.L. 117-169). Monitor and engage on a Senate FY 2025 National Defense Authorization Act (NDAA). Monitor and engage on legislative action related to the 2025 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Acts. Monitor and engage on legislative action related to the 2025 Department of the Interior, Environment, and Related Agencies Appropriations Acts. Monitor and engage on legislative action related to the 2025 Senate Intelligence Authorization Act. H.R. 4288, Labeling Uniformity Act. H.R. 7174, Ensuring Pathways to Innovative Cures (EPIC) Act. H.R. 8070, Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025. H.R. 8512, Intelligence Authorization Act for Fiscal Year 2025.

Monitor and engage on legislative and administrative action related to Medicare and Medicaid policy. Monitor the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169).

Monitor and engage on legislative and administrative action related to health care policy. Monitor and engage on legislative and administrative action related to womens health issues. Monitor and engage on legislative and administrative action related to over-the-counter consumer care products. Monitor and engage on legislative and administrative action related to dietary supplements. Monitor and engage on legislative and administrative action related to servicing of medical device equipment. Monitor and engage on legislative and administrative action related to FDA monograph reform and user fees. Monitor and engage on legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor and engage on legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor and engage on legislative and administrative action related to 340B drug discount program. Monitor and engage on legislative and administrative action related to drug supply chain issues, including pharmacy benefit manager reform. Monitor and engage on legislative and administrative action related to copay assistance. Monitor and engage on legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor and engage on legislative and administrative action related to long-acting reversable contraception usage. Monitor and engage on legislative and administrative action related to access to treatments for kidney patients. Monitor and engage on legislative and administrative action related to broader insurance coverage of supplemental imaging procedures for women with dense breast tissue. Monitor and engage on legislative and administrative action related to phenylephrine. Monitor and engage on legislative and administrative action related to e-labeling. Monitor and engage on legislative and administrative action related to DEA-determined pseudoephedrine quotas. H.R. 3086, Find It Early Act. H.R. 3433, Give Kids a Chance Act of 2023. H.R. 7384, A bill to amend the Federal Food, Drug, and Cosmetic Act to extend the authority of the Secretary of HHS to issue priority review vouchers to encourage treatments for rare pediatric diseases. S. 4583, Creating Hope Reauthorization Act of 2024.

Monitor and engage on legislative and administrative action related to intellectual property protection. Monitor and engage on legislative and administrative action related to 35 USC 101 reform.

Monitor and engage on legislative and federal activity related to tax reform. Monitor and engage on legislative and administrative action related to corporate and international tax, including issues related to tax code sections 245A, 951A, 59A, 163(j), 174, and 965. Monitor and engage on legislative and administrative action related to implementation of P.L. 115-97, Tax Cuts and Jobs Act. Monitor and engage on legislative and administrative action related to including dietary supplements as reimbursable expenses in tax-preferred savings accounts. Monitor and engage on legislative and administrative issues related to foreign tax credit regulations. Monitor and engage on the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169), including the section 45Z tax credit and the sustainable aviation fuel tax credit.

Monitor and engage on legislative and administrative action related to health care policy. Monitor and engage on legislative and administrative action related to womens health issues. Monitor and engage on legislative and administrative action related to over-the-counter consumer care products. Monitor and engage on legislative and administrative action related to dietary supplements. Monitor and engage on legislative and administrative action related to servicing of medical device equipment. Monitor and engage on legislative and administrative action related to FDA monograph reform and user fees. Monitor and engage on legislative and administrative action related to the switch of prescription medications to over-the-counter medications. Monitor and engage on legislative and administrative action related to drug pricing, including rulemakings at HHS. Monitor and engage on legislative and administrative action related to 340B drug discount program. Monitor and engage on legislative and administrative action related to drug supply chain issues, including pharmacy benefit manager reform. Monitor and engage on legislative and administrative action related to copay assistance. Monitor and engage on legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP). Monitor and engage on legislative and administrative action related to long-acting reversable contraception usage. Monitor and engage on legislative and administrative action related to access to treatments for kidney patients. Monitor and engage on legislative and administrative action related to broader insurance coverage of supplemental imaging procedures for women with dense breast tissue. Monitor and engage on legislative and administrative action related to phenylephrine. Monitor and engage on legislative and administrative action related to e-labeling. Monitor and engage on legislative and administrative action related to DEA-determined pseudoephedrine quotas. H.R. 3086, Find It Early Act. H.R. 7384, A bill to amend the Federal Food, Drug, and Cosmetic Act to extend the authority of the Secretary of HHS to issue priority review vouchers to encourage treatments for rare pediatric diseases. S. 4583, A bill to amend the Federal Food, Drug, and Cosmetic Act to extend the authority of the Secretary of HHS to issue priority review vouchers to encourage treatments for rare pediatric diseases.

BAYER CORPORATION (CONSOLIDATED REPORT)

BAYER CORPORATION (CONSOLIDATED REPORT)

BAYER CORPORATION (CONSOLIDATED REPORT)

BAYER CORPORATION (CONSOLIDATED REPORT)